Long-Term Assets: The sum of all assets classified as non-current.
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) had Long-Term Assets of $29.15M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-21.12M |
|
-- |
|
-- |
|
$23.32M |
|
$-23.32M |
|
$2.17M |
|
$-21.15M |
|
$-21.15M |
|
$-21.13M |
|
$-21.13M |
|
$-21.13M |
|
$-21.13M |
|
$-23.32M |
|
$-21.32M |
|
40.34M |
|
40.34M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$100.41M |
|
$4.51M |
|
|
Long-Term Assets |
$29.15M |
$129.56M |
|
$12.72M |
|
-- |
|
$14.36M |
|
$27.08M |
|
$102.48M |
|
$82.11M |
|
$102.48M |
|
40.35M |
|
| Cash Flow Statement Financials | |
$-33.01M |
|
$-0.04M |
|
$0.00M |
|
$112.40M |
|
$87.78M |
|
$-24.62M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.61% |
|
-25.73% |
|
-16.31% |
|
-20.61% |
|
$2.54 |
|
$-0.82 |
|
$-0.82 |
|